(Q37091495)

18 August 2017

1 reference

title

Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis (English)

1 reference

18 August 2017

0 references

0 references

Douglas Osei-Hyiaman

2

0 references

author name string

George Kunos

series ordinal

1

1 reference

18 August 2017

21 February 2008

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

18 August 2017

1 reference

18 August 2017

294

1 reference

18 August 2017

5

1 reference

18 August 2017

G1101-4

1 reference

The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake

18 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

A neutral CB1 receptor antagonist reduces weight gain in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet beta-cells via CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

The endocannabinoid system as an emerging target of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00057.2008

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00057.2008

1 reference

18 August 2017

1 reference

PubMed ID

18292184